302 related articles for article (PubMed ID: 24030947)
1. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.
Ricci G; Scionti I; Sera F; Govi M; D'Amico R; Frambolli I; Mele F; Filosto M; Vercelli L; Ruggiero L; Berardinelli A; Angelini C; Antonini G; Bucci E; Cao M; Daolio J; Di Muzio A; Di Leo R; Galluzzi G; Iannaccone E; Maggi L; Maruotti V; Moggio M; Mongini T; Morandi L; Nikolic A; Pastorello E; Ricci E; Rodolico C; Santoro L; Servida M; Siciliano G; Tomelleri G; Tupler R
Brain; 2013 Nov; 136(Pt 11):3408-17. PubMed ID: 24030947
[TBL] [Abstract][Full Text] [Related]
2. Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling.
Scionti I; Fabbri G; Fiorillo C; Ricci G; Greco F; D'Amico R; Termanini A; Vercelli L; Tomelleri G; Cao M; Santoro L; Percesepe A; Tupler R
J Med Genet; 2012 Mar; 49(3):171-8. PubMed ID: 22217918
[TBL] [Abstract][Full Text] [Related]
3. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy.
Scionti I; Greco F; Ricci G; Govi M; Arashiro P; Vercelli L; Berardinelli A; Angelini C; Antonini G; Cao M; Di Muzio A; Moggio M; Morandi L; Ricci E; Rodolico C; Ruggiero L; Santoro L; Siciliano G; Tomelleri G; Trevisan CP; Galluzzi G; Wright W; Zatz M; Tupler R
Am J Hum Genet; 2012 Apr; 90(4):628-35. PubMed ID: 22482803
[TBL] [Abstract][Full Text] [Related]
4. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
[TBL] [Abstract][Full Text] [Related]
5. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.
Nikolic A; Ricci G; Sera F; Bucci E; Govi M; Mele F; Rossi M; Ruggiero L; Vercelli L; Ravaglia S; Brisca G; Fiorillo C; Villa L; Maggi L; Cao M; D'Amico MC; Siciliano G; Antonini G; Santoro L; Mongini T; Moggio M; Morandi L; Pegoraro E; Angelini C; Di Muzio A; Rodolico C; Tomelleri G; Grazia D'Angelo M; Bruno C; Berardinelli A; Tupler R
BMJ Open; 2016 Jan; 6(1):e007798. PubMed ID: 26733561
[TBL] [Abstract][Full Text] [Related]
6. Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD).
Dai Y; Li P; Wang Z; Liang F; Yang F; Fang L; Huang Y; Huang S; Zhou J; Wang D; Cui L; Wang K
J Med Genet; 2020 Feb; 57(2):109-120. PubMed ID: 31506324
[TBL] [Abstract][Full Text] [Related]
7. [Facioscapulohumeral muscular dystrophy type 2].
Sacconi S; Desnuelle C
Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
[TBL] [Abstract][Full Text] [Related]
8. Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies.
Nikolic A; Jones TI; Govi M; Mele F; Maranda L; Sera F; Ricci G; Ruggiero L; Vercelli L; Portaro S; Villa L; Fiorillo C; Maggi L; Santoro L; Antonini G; Filosto M; Moggio M; Angelini C; Pegoraro E; Berardinelli A; Maioli MA; D'Angelo G; Di Muzio A; Siciliano G; Tomelleri G; D'Esposito M; Della Ragione F; Brancaccio A; Piras R; Rodolico C; Mongini T; Magdinier F; Salsi V; Jones PL; Tupler R
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290091
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy.
Ruggiero L; Mele F; Manganelli F; Bruzzese D; Ricci G; Vercelli L; Govi M; Vallarola A; Tripodi S; Villa L; Di Muzio A; Scarlato M; Bucci E; Antonini G; Maggi L; Rodolico C; Tomelleri G; Filosto M; Previtali S; Angelini C; Berardinelli A; Pegoraro E; Moggio M; Mongini T; Siciliano G; Santoro L; Tupler R
JAMA Netw Open; 2020 May; 3(5):e204040. PubMed ID: 32356886
[TBL] [Abstract][Full Text] [Related]
10. Monosomy 18p is a risk factor for facioscapulohumeral dystrophy.
Balog J; Goossens R; Lemmers RJLF; Straasheijm KR; van der Vliet PJ; Heuvel AVD; Cambieri C; Capet N; Feasson L; Manel V; Contet J; Kriek M; Donlin-Smith CM; Ruivenkamp CAL; Heard P; Tapscott SJ; Cody JD; Tawil R; Sacconi S; van der Maarel SM
J Med Genet; 2018 Jul; 55(7):469-478. PubMed ID: 29563141
[TBL] [Abstract][Full Text] [Related]
11. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.
Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC
Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448
[TBL] [Abstract][Full Text] [Related]
12. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.
Lemmers RJ; Wohlgemuth M; van der Gaag KJ; van der Vliet PJ; van Teijlingen CM; de Knijff P; Padberg GW; Frants RR; van der Maarel SM
Am J Hum Genet; 2007 Nov; 81(5):884-94. PubMed ID: 17924332
[TBL] [Abstract][Full Text] [Related]
13. D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection.
Lemmers RJ; Osborn M; Haaf T; Rogers M; Frants RR; Padberg GW; Cooper DN; van der Maarel SM; Upadhyaya M
Neurology; 2003 Jul; 61(2):178-83. PubMed ID: 12874395
[TBL] [Abstract][Full Text] [Related]
14. Pearls in the junk: dissecting the molecular pathogenesis of facioscapulohumeral muscular dystrophy.
Dmitriev P; Lipinski M; Vassetzky YS
Neuromuscul Disord; 2009 Jan; 19(1):17-20. PubMed ID: 18974002
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of the D4Z4 locus associated with facioscapulohumeral muscular dystrophy 1A in Shanghai population.
Zhang YZ; Sun SC; Wu HC; Fan QS; Song YJ; Yu W; Jeanpierre M; Urtizberea JA
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):380-2. PubMed ID: 16086272
[TBL] [Abstract][Full Text] [Related]
16. Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.
Ricci G; Zatz M; Tupler R
Curr Mol Med; 2014; 14(8):1052-1068. PubMed ID: 25323867
[TBL] [Abstract][Full Text] [Related]
17. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.
Lemmers RJ; Wohlgemuth M; Frants RR; Padberg GW; Morava E; van der Maarel SM
Am J Hum Genet; 2004 Dec; 75(6):1124-30. PubMed ID: 15467981
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the complexity of the 4q and 10q subtelomeres by molecular combing in healthy individuals and patients with facioscapulohumeral dystrophy.
Nguyen K; Broucqsault N; Chaix C; Roche S; Robin JD; Vovan C; Gerard L; Mégarbané A; Urtizberea JA; Bellance R; Barnérias C; David A; Eymard B; Fradin M; Manel V; Sacconi S; Tiffreau V; Zagnoli F; Cuisset JM; Salort-Campana E; Attarian S; Bernard R; Lévy N; Magdinier F
J Med Genet; 2019 Sep; 56(9):590-601. PubMed ID: 31010831
[TBL] [Abstract][Full Text] [Related]
20. Nanopore-based single molecule sequencing of the D4Z4 array responsible for facioscapulohumeral muscular dystrophy.
Mitsuhashi S; Nakagawa S; Takahashi Ueda M; Imanishi T; Frith MC; Mitsuhashi H
Sci Rep; 2017 Nov; 7(1):14789. PubMed ID: 29093467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]